New drugs for neuraxial blockade

Current Opinion in Anaesthesiology

Volumn 12, Issue 5, 1999, Pages 551-557

  Schug, Stephan A ^a,d   Buerkle, Hartmut ^b   Moharib, Magdi ^c   Cardwell, Hester M D ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; BUPIVACAINE; CLONIDINE; KETAMINE; LOCAL ANESTHETIC AGENT; NEOSTIGMINE; OPIATE; ROPIVACAINE; SUFENTANIL;

CONVULSION; DROWSINESS; EPIDURAL ANESTHESIA; HYPERTENSION; MUSCLE WEAKNESS; NAUSEA; OBSTETRIC ANESTHESIA; POSTOPERATIVE ANALGESIA; PRIORITY JOURNAL; PRURITUS; REGIONAL ANESTHESIA; REVIEW; SPINAL ANESTHESIA; TACHYCARDIA; VOMITING;

EID: 0033386272     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-199910000-00011     Document Type: Review

References (81)

1. Cascio MG, Gaiser RR, Camann WR, Venkateswaran P, Hawkins J, McCarthy D. Comparative evaluation of four different infusion rates of ropivacaine (2†mg/ml) for epidural labor analgesia. Reg Anesth Pain Med 1998; 23(6):548-553.
2. Owen MD, D'Angelo R, Gerancher JR, Thompson JM, Foss ML, Babb JD, Eisenach JC. > 0.125% ropivacaine is similar to 0.125% bupivacaine for labor analgesia using patient-controlled epidural infusion. Anesth Analg 1998; 86:527-531. This interesting study demonstrates the possibility of using lower doses, thus minimizing the side effects of either ropivacaine or bupivacaine with patient-controlled epidural analgesia. However, a potential benefit of ropivacaine was not demonstrated.
3. Irestedt L, Ekblom A, Olofsson C, Dahlstrom AC, Emanuelsson BM. Pharmacokinetics and clinical effect during continuous epidural infusion with rupivacaine 2.5 mg/ml or bupivacaine 2.5 mg/ml for labour pain relief. Acta Anesthesiol Scand 1998; 42:890-896.
4. Levin A, Datta S, Camann WR. Intrathecal ropivacaine for labor analgesia: a comparison with bupivacaine. Anesth Analg 1998; 87:624-627. This study clearly demonstrates the wide therapeutic index of ropivacaine when administered intrathecally with two different concentrations.
5. Ivani G, Lampugnani E, Torre M, Calevo Maria G, DeNegri P, Borrometi F, et al. Comparison of ropivacaine with bupivacaine for paediatric caudal block. Br J Anaesth 1998; 81:247-248.
6. Ivani G, Mereto N, Lampugnani E, Negri PD, Torre M, Mattioli G, et al. Ropivacaine in paediatric surgery: preliminary results. Paediatr Anaesth 1998; 8:127-129.
7. Da Conceicao MJ, Coelho L. Caudal anaesthesia with 0.375% ropivacaine or 0.375% bupivacaine in paediatric patients. Br J Anaesth 1998; 80:507-508. In this study, the higher caudal ropivacaine concentration still demonstrates less intense and shorter duration of motor blockade compared to bupivacaine, a credit for the drug in this indication.
8. Muldoon T, Milligan K, Quinn P, Connolly DC, Nilsson K. Comparison between extradural infusion of ropivacaine or bupivacaine for the prevention of postoperative pain after total knee arthroplasty. Br J Anaesth 1998; 80:680-681.
9. Brodner G, Mertes N, Van Aken H, Pogatzki E, Buerkle H, Marcus MA, Mollhoff T. Epidural analgesia with local anesthetics after abdominal surgery: earlier motor recovery with 0.2% ropivacaine than 0.175% bupivacaine. Anesth Analg 1999; 88:128-133. This first study of ropivacaine with an opioid demonstrates a benefit of ropivacaine with regard to motor blockade - however, the chosen bupivacaine concentration is unusually high for this indication and a relatively large amount of sufentanil might have contributed to the comparable quality of analgesia.
10. Sandler AN, Arlander E, Finucane BT, Taddio A, Chan V, Milner A, et al. Pharmacokinetics of three doses of epidural ropivacaine during hysterectomy and comparison with bupivacaine. Can J Anaesth 1998; 45:843-849. The clinical behaviour of both ropivacaine and bupivacaine is well explained by the pharmacokinetic findings in this study.
11. Plowman AN, Bolsin S, Mather LE. Central nervous system toxicity attributable to epidural ropivacaine hydrochloride. Anaesth Intensive Care 1998; 26:204-206.
12. Abouleish EI, Elias M, Nelson C. Ropivacaine-induced seizure after extradural anaesthesia. Br J Anaesth 1998; 80:843-844.
13. Polley LS, Columb MO, Naughton NN, Wagner DS, van de Ven CJ. Relative analgesic potencies of ropivacaine and bupivacaine for epidural analgesia in labor: implications for therapeutic indexes. Anesthesiology 1999; 90:944-950. Using the MLAC technique, this study found a potency ratio of 0.6 for ropivacaine versus bupivacaine for epidural analgesia in labor.
14. Capogna G, Celleno D, Fusco P, Lyons G, Columb M. Relative potencies of bupivacaine and ropivacaine for analgesia in labour. Br J Anaesth 1999; 82:371-373. Similar study design with identical results to reference 13.
15. Writer WDR, Stienstra R, Eddleston JM, Gatt SP, Griffin R, Gutsche BB, et al. Neonatal outcome and mode of delivery after epidural analgesia for labour with ropivacaine and bupivacaine: a prospective meta-analysis. Br J Anaesth 1998; 81:713-717. Meta-analysis of all comparative trials of epidural ropivacaine versus bupivacaine showing better NACS, less motor block and less instrumental deliveries with ropivacaine.
16. Huang YF, Pryor ME, Mather LE, Veering BT. Cardiovascular and central nervous system effects of intravenous levobupivacaine and bupivacaine in sheep. Anesth Analg 1998; 86:797-804. This animal study shows the superior margin of safety of levobupivacaine over racemic bupivacaine.
17. Bardsley H, Gristwood R, Baker H, Watson N, Nimmo W. A comparison of the cardiovascular effects of levobupivacaine and rac-bupivacaine following intravenous administration to healthy volunteers. Br J Clin Pharm 1998; 46:245-249. Confirming the results of 16 in human volunteers.
18. Ericson AC, Avesson M. Effects of ropivacaine, bupivacaine and S-(-)-bupivacaine on the ECG after rapid IV injections to conscious rats. International Monitor on Regional Anaesthesia 1996; 8:51.
19. Cox CR, Faccenda KA, Gilhooly C, Bannister J, Scott NB, Morrison LMM. Extradural S-(-)-bupivacaine: Comparison with racemic RS-bupivacaine. Br J Anaesth 1998; 80:289-293. Direct comparison revealed similar properties of both local anaesthetics.
20. Lyons G, Columb M, Wilson RC, Johnson RV. Epidural pain relief in labour: potencies of levobupivacaine and racemic bupivacaine. Br J Anaesth 1998; 81:899-901. MLAC study showing identical potency (ratio 0.98).
21. Arkoosh VA, Cooper M, Norris MC, Boxer L, Ferouz F, Silverman NS, et al. Intrathecal sufentanil dose response in nulliparous patients. Anesthesiology 1998; 89:364-370. An informative study of various intrathecal sufentanil doses for labor analgesia and their effects on the parturients.
22. Norris MC, Fogel ST, Holtmann B. Intrathecal sufentanyl (5 vs. 10 microg) for labor analgesia: efficacy and side effects. Reg Anesth Pain Med 1988; 23:252-257.
23. Gaiser RR, Cheek TG, Gutsche BB. Comparison of three different doses of intrathecal fentanyl and sufentanil for labor analgesia. J Clin Anesth 1998; 10:488-493.
24. Fournier R, Gamulin Z, Van Gessel E. Respiratory depression after 5 micrograms of intrathecal sufentanil. Anest Analg 1998; 87:1377-1378. A warning example of the potential risks of using potent opioids, even in small doses intrathecally.
25. Katsiris S, Williams S, Leighton BL, Halpern S. Respiratory arrest following intrathecal injection of sufentanil and bupivacaine in a parturient. Can J Anaesth 1998; 45:880-883. Another similar case.
26. Sia AT, Chong JL, Tay DH, Lo WK, Chen LH, Chiu JW. Intrathecal sufentanil as the sole agent in combined spinal-epidural analgesia for the ambulatory parturient. Can J Anaesth 1998; 45:620-625.
27. Gautier PE, De Kock M, Fanard L, Van Steenberge A, Hody JL. Intrathecal clonidine combined with sufentanil for labor analgesia. Anesthesiology 1998; 88:651-656.
28. Mercier FG, Dounas M, Bouaziz H, Des Mesnards-Smaja V, Foiret C, Vestermann MN, et al. The effect of adding a minidose of clonidine to intrathecal sufentanil for labor analgesia. Anesthesiology 1998; 89:594-601.
29. Ngiam SK, Chong JL. The addition of intrathecal sufentanil and fentanyl to bupivacaine for caesarean section. Singapore Med J 1998; 39:290-294.
30. Lin BC, Lin PC, Lai YY, Huang SJ, Yeh FC. The maternal and fetal effects of the addition of sufentanil to 0.5% spinal bupivacaine for caesarean delivery. Acta Anaesthesiol Sin 1998; 36:143-148.
31. Camann W, Abouleish A, Eisenach J, Hood D, Datta S. Intrathecal sufentanil and epidural bupivacaine for labor analgesia: dose-response of individual agents and in combination. Reg Anesth Pain Med 1998; 23:457-462. An interesting study demonstrating the synergistic effects when sufentanil and bupivacaine were separately administered in two different compartments.
32. Vercauteren MP, Geernaert K, Hoffmann VL, Dohmen D, Adriaensen HA. Postoperative intrathecal patient-controlled analgesia with bupivacaine, sufentanil or a mixture of both. Anaesthesia 1998; 53:1022-1027.
33. Olofsson C, Ekblom A, Ekman-Ordeberg G, Irestedt L. Obstetric outcome following epidural analgesia with bupivacaine-adrenaline 0.25% or bupivacaine 0.125% with sufentanil - a prospective randomized controlled study in 1000 parturients. Acta Anaesthesiol Scand 1998; 42:284-292. An extensive study of a large number of parturients highlighting the superiority of low dose local anaesthetic with sufentanil for epidural labor analgesia.
34. Vercauteren MP, Van Den Bergh L, Kartawiadi SL, Van Boxem K, Hoffmann VL. Addition of bupivacaine to sufentanil in patient-controlled epidural analgesia after lower limb surgery in young adults: effect on analgesia and micturition. Reg Anesth Pain Med 1998; 23:182-188.
35. Dunn SM, Connelly NR, Steinberg RB, Lewis TJ, Bazzell CM, Klatt JL, Parker RK. Intrathecal sufentanil versus epidural lidocaine with epinephrine and sufentanil for early labor analgesia. Anest Analg 1998; 87:331-335.
36. Pan HL, Chen SR, Eisenach JC. Intrathecal clonidine alleviates allodynia in neuropathic rats: interaction with spinal muscarinic and nicotinic receptors. Anesthesiology 1999; 90:509-514.
37. Pan HL, Chen SR, Eisenach JC. Role of spinal NO in antiallodynic effect of intrathecal clonidine in neuropathic rats. Anesthesiology 1998; 89:1518-1523.
38. Filos KS, Goudas LC, Patroni O, Polyzou V. Hemodynamic and analgesic profile after intrathecal clonidine in humans. A dose-response study. Anesthesiology 1994; 81:591-601.
39. Mercier FJ, Dounas M, Bouaziz H, Des Mesnards-Smaja V, Foiret C, Vestermann MN, et al. The effect of adding a minidose of clonidine to intrathecal sufentanil for labour analgesia. Anesthesiology 1998; 89:594-601.
40. Gautier PE, De Kock M, Fanard L, Van Steenburge A, Hody JL. Intrathecal clonidine combined with sufentanil for labour analgesia. Anesthesiology 1998; 88:651-656. An informative study comparing intrathecal clonidine and sufentanil and high-lighting the pharmacological effects of various doses and combinations.
41. De Kock M, Wiederkher P, Laghmiche A, Scholtes JL. Epidural clonidine used as a sole analgesic agent during and after abdominal surgery. A dose-response study. Anesthesiology 1997; 86:285-292.
42. Engel JM, Hussmann R, Gurtler KH, Menges T, Hempelmann G. Dose-response relationship of clonidine with epidural administration of ropivacaine in orthopaedic procedures of the lower extremities. Anaesthesist 1998; 47:565-570.
43. Claes B, Soetens M, Van Zundert A, Datta S. Clonidine added to bupivacaine-epinephrine-sufentanil improves epidural analgesia during childbirth. Reg Anesth Pain Med 1998; 23:540-547. A good example of what balanced analgesia could be like in the future.
44. 2 tension effects of clonidine in paediatric caudal analgesia. Paediatr Anaesth 1998; 8:145-148. Epidural clonidine has systemic effects, too!
45. Chiaa YY, Liu K, Liu YC, Chang HC, Wong CS. Adding ketamine in multimodal patient-controlled epidural regimen reduces postoperative pain and analgesic consumption. Anesth Analg 1998; 86:1245-1249. This study confirms that multimodal regimens with reduced doses are safe and promising for postoperative epidural analgesia.
46. Weir PS, Fee JP. Double-blind comparison of extradural block with three bupivacaine-ketamine mixtures in knee arthroplasty. Br J Anaesth 1998; 80:299-301. The possible synergistic effect of the epidural ketamine in this study was probably masked by the clinically adequate dose of bupivacaine.
47. Hawksworth C, Serpell M. Intrathecal anesthesia with ketamine. Reg Anesth Pain Med 1998; 283-288.
48. Abdel-Ghaffar ME, Abdulatif MA, al-Ghamdi A, Mowafi H, Anwar A. Epidural ketamine reduces post-operative epidural PCA consumption of fentanyl/bupivacaine. Can J Anaesh 1998; 45:103-109.
49. Kucuk N, Kizilkaya M, Tokdemir M. Preoperative epidural ketamine does not have a postoperative opioid sparing effect. Anesth Analg 1988; 87:103-106.
50. Hartrick CT, Wise JJ, Patterson JS. Preemptive intrathecal ketamine delays mechanical hyperalgesia in the neuropathic rat. Anesth Analg 1998; 86:557-560.
51. Takahashi H, Miyazaki M, Nanbu T, Yanagida H, Morita S. The NMDA-receptor antagonist ketamine abolishes neuropathic pain after epidural administration in a clinical case. Pain 1998; 75:391-394. Promising case report confirmed by the clinical experience of many others (e.g. next reference).
52. Lin TC, Wong CS, Chen FC, Lin SY, Ho ST. Long-term epidural ketamine, morphine and bupivacaine attenuate reflex sympathetic dystrophy neuralgia. Can J Anaesth 1998; 45:175-177. See above.
53. Eisenach JC. Muscarinic-mediated analgesia. Life Sci 1999; 64:549-554. Excellent review about muscarinic antinociception.
54. Yaksh T, Dirksen R, Harty G. Antinociceptive effects of intrathecally injected cholinomimetic drugs in the rat and cat. European Journal of Pharmacology 1985; 117:81-85.
55. Shafer SL, Eisenach JC, Hood DD, Tong C. Cerebrospinal fluid pharmacokinetics and pharmacodynamics of intrathecal neostigmine methylsulfate in humans. Anesthesiology 1998; 89:1074-1088. Pharmacokinetic and pharmacodynamic analyses of intrathecal neostigmine performed with NONMEM analysis revealing a triexponential disposition function with a large intersubject variability.
56. Lavand'homme P, Pan HL, Eisenach JC. Intrathecal neostigmine, but not sympathectomy, relieves mechanical allodynia in a rat model of neuropathic pain. Anesthesiology 1996; 89:493-499.
57. Hwang JH, Hwang KS, Leem JK, Park PH, Han SM, Lee DM. The antiallodynic effects of intrathecal cholinesterase inhibitors in a rat model of neuropathic pain. Anesthesiology 1999; 90:492-499.
58. Naguib M, Yaksh TL. Characterization of muscarinic receptor subtypes that mediate antinociception in the rat spinal cord. Anesth Analg 1997; 85:847-853. Rodent study suggesting by agonist/antagonist experiments that the M1 and possibly the M3 muscarinic receptors mediate spinal antinociception in the rat.
59. Pan HL, Song HK, Eisenach JC. Effects of intrathecal neostigmine, bupivacaine, and their combination on sympathetic nerve activity in rats. Anesthesiology 1998; 88:481-486.
60. Bouaziz H, Tong C, Eisenach JC. Postoperative analgesia from intrathecal neostigmine in sheep. Anesth Analg 1995; 80:1140-1144.
61. Hood DD, Eisenach JC, Tuttle R. Phase I safety assessment of intrathecal neostigmine methylsulfate in humans. Anesthesiology 1995; 82:331-343. Study in human volunteers showing that the incidence and severity of the adverse events from intrathecal neostigmine (mainly vomiting, nausea and leg weakness) appears to be affected by dose, method of administration, and baricity of solution.
62. Lauretti GR, Reis MP, Prado WA, Klamt JG. Dose-response study of intrathecal morphine versus intrathecal neostigmine, their combination, or placebo for postoperative analgesia in patients undergoing anterior and posterior vaginoplasty. Anesth Analg 1996; 82:1182-1187.
63. Williams JS, Tong C, Eisenach JC. Neostigmine counteracts spinal clonidine-induced hypotension in sheep. Anesthesiology 1993; 78:301-307.
64. Abram SE, Winne RP. Intrathecal acetyl cholinesterase inhibitors produce analgesia that is synergistic with morphine and clonidine in rats. Anesth Analg 1995; 81:501-507.
65. Pan PM, Huang CT, Wei TT, Mok MS. Enhancement of analgesic effect of intrathecal neostigmine and clonidine on bupivacaine spinal anesthesia. Reg Anesth Pain Med 1998; 23:49-56.
66. Pan HL, Chen SR, Eisenach JC. Role of spinal NO in antiallodynic effect of intrathecal clonidine in neuropathic rats. Anesthesiology 1998; 89:1518-1523.
67. Lauretti GR, Reis MP. Subarachnoid neostigmine does not affect blood pressure or heart rate during bupivacaine spinal anesthesia. Reg Anesth 1996; 21:586-591.
68. Lauretti GR, Hood DD, Eisenach JC, Pfeifer BL. A multi-center study of intrathecal neostigmine for analgesia following vaginal hysterectomy. Anesthesiology 1998; 89:913-918. Women scheduled for vaginal hysterectomy were randomized to receive an intrathecal injection of 2 ml bupivacaine, 0.75%, in dextrose plus either 1 ml saline or 25, 50, or 75 μg neostigmine, suggesting that analgesia from intrathecal neostigmine may occur at doses less than 50 μg. However, in these doses, neostigmine did not reduce spinal bupivacaine-induced hypotension but increased the need for treatment of nausea.
69. Yaksh TL, Grafe MR, Malkmus S, Rathbun ML, Eisenach JC. Studies on the safety of chronically administered intrathecal neostigmine methylsulfate in rats and dogs. Anesthesiology 1995; 82:412-427. Studies on safety of new or old drugs applied through a neuraxial route should be preceded by safety studies, such as one performed for the spinal use of neostigmine.
70. Liu S, Hodgson P, Moore J, Trautman W. Dose-response effects of spinal nestigmine added to bupivacaine spinal anesthesia in volunteers. Anesthesiology 1999; 90:700-707.
71. Poon A, Sawynok J. Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat. Pain 1998; 74:235-245.
72. Sjolund KF, von Heijne M, Hao JX, Xu XJ Sollevi, A, Wiesenfeld-Hallin, Z. Intrathecal administration of the adenosine A1 receptor agonist R-phenylisopropyl adenosine reduces presumed pain bohaviour in a rat model of central pain. Neurosci Lett 1998; 243:89-92.
73. Khandwala H, Zhang Z, Loomis CW. Inhibition of strychnine-allodynia is mediated by spinal adenosine A1- but not A2-receptors in the rat. Brain Res 1998; 808:106-109.
74. Choca J, Grenn R, Proudfit, H. Adenosine A1 and A2 receptors of the substantia gelatinosa are located predominantly on intrinsic neurons: an autoradiographic study. Journal of Pharmacology and Experimental Therapeutics 1988; 247:757-764.
75. Nakamura I, Ohta Y, Kemmotsu O. Characterization of adenosine receptors mediating spinal sensory transmission related to nociceptive information in the rat. Anesthesiology 1997; 87:577-584.
76. Sawynok J. Adenosine receptor activation and nociception. European Journal of Pharmacology 1998; 317:1-11.
77. Rane K, Segerdahl M, Goiny M, Sollevi A. Intrathecal adenosine administration: a phase 1 clinical safety study in healthy volunteers, with additional evaluation of its influence on sensory thresholds and experimental pain. Anesthesiology 1998; 89:1108-1115.
78. Lee YW, Yaksh T. Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists. Journal of Pharmacology and Experimental Therapeutics 1996; 277:1642-1648.
79. Guieu R, Peragut J, Roussel P, Hassani H, Sampieri F, Bechis G, et al. Adenosine and neuropathic pain. Pain 1996; 68:271-274.
80. Karlsten R, Gordh T. An A1-selective adenosine agonist abolishes allodynia elicited by vibration and touch after intrathecal injection. Anesth Analg 1995; 80: 844-847.
81. Lindblom U, Nordfors L-O, Sollevi A, Sydow O. Adenosine for pain relief in a patient with intractable secondary erythromelalgia. European Journal of Pain 1997; 1:229-302.